7Baggers

We provide you with 20 years of free, institutional-grade data for GLPG stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GLPG. Explore the full financial landscape of GLPG stock.

Reported DateCIKTickerType
2024-02-231421876GLPG6-KUrl
2024-02-161421876GLPG6-KUrl
2024-02-061421876GLPG6-KUrl
2024-01-051421876GLPG6-KUrl
2024-01-041421876GLPG6-KUrl
2024-01-041421876GLPG6-KUrl
2023-12-211421876GLPG6-KUrl
2023-12-121421876GLPG6-KUrl
2023-12-121421876GLPG6-KUrl
2023-11-031421876GLPG6-KUrl
2023-11-021421876GLPG6-KUrl
2023-09-201421876GLPG6-KUrl
2023-08-301421876GLPG6-KUrl
2023-08-041421876GLPG6-KUrl
2023-06-151421876GLPG6-KUrl
2023-06-131421876GLPG6-KUrl
2023-06-121421876GLPG6-KUrl
2023-05-261421876GLPG6-KUrl
2023-05-231421876GLPG6-KUrl
2023-05-091421876GLPG6-KUrl
2023-05-051421876GLPG6-KUrl
2023-05-021421876GLPG6-KUrl
2023-05-021421876GLPG6-KUrl
2023-04-261421876GLPG6-KUrl
2023-04-251421876GLPG6-KUrl
2023-03-311421876GLPG6-KUrl
2023-03-271421876GLPG6-KUrl
2023-03-231421876GLPG20-FUrl
2023-03-231421876GLPG6-KUrl
2023-02-281421876GLPG6-KUrl
2023-02-241421876GLPG6-KUrl
2023-02-101421876GLPG6-KUrl
2023-02-081421876GLPG6-KUrl
2023-01-191421876GLPG6-KUrl
2023-01-101421876GLPG6-KUrl
2023-01-051421876GLPG6-KUrl
2023-01-051421876GLPG6-KUrl
2022-12-231421876GLPG6-KUrl
2022-12-131421876GLPG6-KUrl
2022-11-141421876GLPG6-KUrl
2022-11-091421876GLPG6-KUrl
2022-11-071421876GLPG6-KUrl
2022-11-041421876GLPG6-KUrl
2022-10-171421876GLPG6-KUrl
2022-10-061421876GLPG6-KUrl
2022-10-041421876GLPG6-KUrl
2022-09-271421876GLPG6-KUrl
2022-08-301421876GLPG6-KUrl
2022-08-241421876GLPG6-KUrl
2022-08-191421876GLPG6-KUrl
2022-08-091421876GLPG6-KUrl
2022-08-081421876GLPG6-KUrl
2022-06-231421876GLPG6-KUrl
2022-06-231421876GLPG6-KUrl
2022-06-021421876GLPG6-KUrl
2022-05-311421876GLPG6-KUrl
2022-05-111421876GLPG6-KUrl
2022-05-091421876GLPG6-KUrl
2022-05-061421876GLPG6-KUrl
2022-04-281421876GLPG6-KUrl
2022-04-271421876GLPG6-KUrl
2022-04-111421876GLPG6-KUrl
2022-03-281421876GLPG6-KUrl
2022-03-251421876GLPG6-KUrl
2022-03-241421876GLPG20-FUrl
2022-03-241421876GLPG6-KUrl
2022-02-241421876GLPG6-KUrl
2022-02-071421876GLPG6-KUrl
2022-02-071421876GLPG6-KUrl
2022-01-271421876GLPG6-KUrl
2022-01-261421876GLPG6-KUrl
2022-01-191421876GLPG6-KUrl
2022-01-131421876GLPG6-KUrl
2022-01-101421876GLPG6-KUrl
2021-12-061421876GLPG6-KUrl
2021-11-291421876GLPG6-KUrl
2021-11-171421876GLPG6-KUrl
2021-11-081421876GLPG6-KUrl
2021-10-061421876GLPG6-KUrl
2021-10-061421876GLPG6-KUrl
2021-09-211421876GLPG6-KUrl
2021-09-201421876GLPG6-KUrl
2021-08-311421876GLPG6-KUrl
2021-08-051421876GLPG6-KUrl
2021-07-141421876GLPG6-KUrl
2021-07-141421876GLPG6-KUrl
2021-07-121421876GLPG6-KUrl
2021-06-231421876GLPG6-KUrl
2021-06-081421876GLPG6-KUrl
2021-06-041421876GLPG6-KUrl
2021-05-281421876GLPG6-KUrl
2021-05-191421876GLPG6-KUrl
2021-05-111421876GLPG6-KUrl
2021-05-051421876GLPG6-KUrl
2021-05-031421876GLPG6-KUrl
2021-04-291421876GLPG6-KUrl
2021-04-231421876GLPG6-KUrl
2021-04-091421876GLPG6-KUrl
2021-03-261421876GLPG6-KUrl
2021-03-251421876GLPG20-FUrl
2021-03-251421876GLPG6-KUrl
2021-03-251421876GLPG6-KUrl
2021-03-221421876GLPG6-KUrl
2021-03-041421876GLPG6-KUrl
2021-03-041421876GLPG6-KUrl
2021-02-191421876GLPG6-KUrl
2021-02-101421876GLPG6-KUrl
2021-02-091421876GLPG6-KUrl
2021-01-211421876GLPG6-KUrl
2021-01-111421876GLPG6-KUrl
2021-01-061421876GLPG6-KUrl
2021-01-051421876GLPG6-KUrl
2020-12-151421876GLPG6-KUrl
2020-12-071421876GLPG6-KUrl
2020-12-031421876GLPG6-KUrl
2020-11-301421876GLPG6-KUrl
2020-11-241421876GLPG6-KUrl
2020-11-101421876GLPG6-KUrl
2020-11-091421876GLPG6-KUrl
2020-11-061421876GLPG6-KUrl
2020-11-031421876GLPG6-KUrl
2020-10-271421876GLPG6-KUrl
2020-10-151421876GLPG6-KUrl
2020-10-131421876GLPG6-KUrl
2020-09-301421876GLPG6-KUrl
2020-09-281421876GLPG6-KUrl
2020-09-251421876GLPG6-KUrl
2020-09-211421876GLPG6-KUrl
2020-09-111421876GLPG6-KUrl
2020-08-261421876GLPG6-KUrl
2020-08-191421876GLPG6-KUrl
2020-08-131421876GLPG6-KUrl
2020-08-061421876GLPG6-KUrl
2020-07-241421876GLPG6-KUrl
2020-06-081421876GLPG6-KUrl
2020-06-041421876GLPG6-KUrl
2020-05-291421876GLPG6-KUrl
2020-05-261421876GLPG6-KUrl
2020-05-111421876GLPG6-KUrl
2020-04-291421876GLPG6-KUrl
2020-04-171421876GLPG6-KUrl
2020-04-171421876GLPG6-KUrl
2020-04-161421876GLPG6-KUrl
2020-03-271421876GLPG20-FUrl
2020-03-271421876GLPG6-KUrl
2020-03-171421876GLPG6-KUrl
2020-01-291421876GLPG6-KUrl
2020-01-241421876GLPG6-KUrl
2020-01-151421876GLPG6-KUrl
2020-01-131421876GLPG6-KUrl
2020-01-101421876GLPG6-KUrl
2020-01-101421876GLPG6-KUrl
2019-12-201421876GLPG6-KUrl
2019-12-091421876GLPG6-KUrl
2019-11-261421876GLPG6-KUrl
2019-11-191421876GLPG6-KUrl
2019-11-141421876GLPG6-KUrl
2019-11-121421876GLPG6-KUrl
2019-11-061421876GLPG6-KUrl
2019-11-041421876GLPG6-KUrl
2019-10-291421876GLPG6-KUrl
2019-10-281421876GLPG6-KUrl
2019-10-251421876GLPG6-KUrl
2019-10-231421876GLPG6-KUrl
2019-10-111421876GLPG6-KUrl
2019-10-081421876GLPG6-KUrl
2019-09-251421876GLPG6-KUrl
2019-09-231421876GLPG6-KUrl
2019-09-201421876GLPG6-KUrl
2019-09-191421876GLPG6-KUrl
2019-09-051421876GLPG6-KUrl
2019-09-051421876GLPG6-KUrl
2019-08-291421876GLPG6-KUrl
2019-07-251421876GLPG6-KUrl
2019-07-191421876GLPG6-KUrl
2019-07-151421876GLPG6-KUrl
2019-07-021421876GLPG6-KUrl
2019-06-211421876GLPG6-KUrl
2019-06-171421876GLPG6-KUrl
2019-06-111421876GLPG6-KUrl
2019-05-311421876GLPG6-KUrl
2019-05-061421876GLPG6-KUrl
2019-04-261421876GLPG6-KUrl
2019-04-241421876GLPG6-KUrl
2019-04-111421876GLPG6-KUrl
2019-04-011421876GLPG6-KUrl
2019-03-291421876GLPG20-FUrl
2019-03-291421876GLPG6-KUrl
2019-03-291421876GLPG6-KUrl
2019-03-291421876GLPG6-KUrl
2019-03-211421876GLPG6-KUrl
2019-02-071421876GLPG6-KUrl
2019-01-091421876GLPG6-KUrl
2019-01-071421876GLPG6-KUrl
2019-01-071421876GLPG6-KUrl
2019-01-071421876GLPG6-KUrl
2018-12-261421876GLPG6-KUrl
2018-12-181421876GLPG6-KUrl
2018-11-281421876GLPG6-KUrl
2018-11-271421876GLPG6-KUrl
2018-11-261421876GLPG6-KUrl
2018-11-011421876GLPG6-KUrl
2018-10-261421876GLPG6-KUrl
2018-10-251421876GLPG6-KUrl
2018-10-251421876GLPG6-KUrl
2018-10-231421876GLPG6-KUrl
2018-10-221421876GLPG6-KUrl
2018-10-041421876GLPG6-KUrl
2018-09-241421876GLPG6-KUrl
2018-09-181421876GLPG6-KUrl
2018-09-181421876GLPG6-KUrl
2018-09-141421876GLPG6-KUrl
2018-09-141421876GLPG6-KUrl
2018-09-131421876GLPG6-KUrl
2018-09-131421876GLPG6-KUrl
2018-09-131421876GLPG6-KUrl
2018-09-111421876GLPG6-KUrl
2018-09-061421876GLPG6-KUrl
2018-08-021421876GLPG6-KUrl
2018-07-191421876GLPG6-KUrl
2018-07-091421876GLPG6-KUrl
2018-06-291421876GLPG6-KUrl
2018-06-271421876GLPG6-KUrl
2018-06-211421876GLPG6-KUrl
2018-06-151421876GLPG6-KUrl
2018-06-051421876GLPG6-KUrl
2018-05-221421876GLPG6-KUrl
2018-05-021421876GLPG6-KUrl
2018-05-011421876GLPG6-KUrl
2018-04-271421876GLPG6-KUrl
2018-04-251421876GLPG6-KUrl
2018-04-241421876GLPG6-KUrl
2018-04-161421876GLPG6-KUrl
2018-03-231421876GLPG20-FUrl
2018-03-231421876GLPG6-KUrl
2018-03-211421876GLPG6-KUrl
2018-02-201421876GLPG6-KUrl
2018-01-081421876GLPG6-KUrl
2018-01-031421876GLPG6-KUrl
2017-12-181421876GLPG6-KUrl
2017-12-151421876GLPG6-KUrl
2017-12-121421876GLPG6-KUrl
2017-12-121421876GLPG6-KUrl
2017-11-241421876GLPG6-KUrl
2017-11-221421876GLPG6-KUrl
2017-11-201421876GLPG6-KUrl
2017-11-061421876GLPG6-KUrl
2017-11-021421876GLPG6-KUrl
2017-10-301421876GLPG6-KUrl
2017-09-271421876GLPG6-KUrl
2017-09-221421876GLPG6-KUrl
2017-08-101421876GLPG6-KUrl
2017-07-311421876GLPG6-KUrl
2017-07-281421876GLPG6-KUrl
2017-07-051421876GLPG6-KUrl
2017-06-211421876GLPG6-KUrl
2017-06-201421876GLPG6-KUrl
2017-05-181421876GLPG6-KUrl
2017-05-161421876GLPG6-KUrl
2017-05-081421876GLPG6-KUrl
2017-05-021421876GLPG6-KUrl
2017-04-281421876GLPG6-KUrl
2017-04-261421876GLPG6-KUrl
2017-04-241421876GLPG6-KUrl
2017-04-241421876GLPG6-KUrl
2017-04-181421876GLPG6-KUrl
2017-04-071421876GLPG6-KUrl
2017-04-061421876GLPG6-KUrl
2017-04-041421876GLPG6-KUrl
2017-03-231421876GLPG20-FUrl
2017-03-231421876GLPG6-KUrl
2017-03-221421876GLPG6-KUrl
2017-03-101421876GLPG6-KUrl
2017-02-241421876GLPG6-KUrl
2017-02-241421876GLPG6-KUrl
2017-02-021421876GLPG6-KUrl
2017-01-231421876GLPG6-KUrl
2017-01-171421876GLPG6-KUrl
2016-12-211421876GLPG6-KUrl
2016-12-191421876GLPG6-KUrl
2016-12-121421876GLPG6-KUrl
2016-11-291421876GLPG6-KUrl
2016-11-291421876GLPG6-KUrl
2016-11-251421876GLPG6-KUrl
2016-11-231421876GLPG6-KUrl
2016-11-091421876GLPG6-KUrl
2016-11-091421876GLPG6-KUrl
2016-11-091421876GLPG6-KUrl
2016-10-051421876GLPG6-KUrl
2016-09-271421876GLPG6-KUrl
2016-08-011421876GLPG6-KUrl
2016-08-011421876GLPG6-KUrl
2016-07-141421876GLPG6-KUrl
2016-06-291421876GLPG6-KUrl
2016-06-171421876GLPG6-KUrl
2016-06-021421876GLPG6-KUrl
2016-06-011421876GLPG6-KUrl
2016-05-251421876GLPG6-KUrl
2016-05-251421876GLPG6-KUrl
2016-05-171421876GLPG6-KUrl
2016-05-111421876GLPG6-KUrl
2016-05-021421876GLPG6-KUrl
2016-05-021421876GLPG6-KUrl
2016-04-221421876GLPG6-KUrl
2016-04-071421876GLPG6-KUrl
2016-04-071421876GLPG6-KUrl
2016-04-041421876GLPG6-KUrl
2016-03-281421876GLPG6-KUrl
2016-03-251421876GLPG20-FUrl
2016-03-221421876GLPG6-KUrl
2016-03-221421876GLPG6-KUrl
2016-03-021421876GLPG6-KUrl
2016-02-221421876GLPG6-KUrl
2016-02-051421876GLPG6-KUrl
2016-01-271421876GLPG6-KUrl
2016-01-251421876GLPG6-KUrl
2016-01-191421876GLPG6-KUrl
2016-01-191421876GLPG6-KUrl
2016-01-191421876GLPG6-KUrl
2015-12-231421876GLPG6-KUrl
2015-12-231421876GLPG6-KUrl
2015-12-171421876GLPG6-KUrl
2015-12-151421876GLPG6-KUrl
2015-12-151421876GLPG6-KUrl
2015-11-241421876GLPG6-KUrl
2015-11-201421876GLPG6-KUrl
2015-11-131421876GLPG6-KUrl
2015-11-131421876GLPG6-KUrl
2015-11-131421876GLPG6-KUrl
2015-11-131421876GLPG6-KUrl
2015-11-131421876GLPG6-KUrl
2015-10-201421876GLPG6-KUrl
2015-10-201421876GLPG6-KUrl
2015-10-201421876GLPG6-KUrl
2015-10-061421876GLPG6-KUrl
2015-09-281421876GLPG6-KUrl
2015-08-121421876GLPG6-KUrl
2015-08-061421876GLPG6-KUrl
2015-07-311421876GLPG6-KUrl
2015-06-241421876GLPG6-KUrl
2015-06-191421876GLPG6-KUrl
2015-06-161421876GLPG6-KUrl
2015-06-111421876GLPG6-KUrl
2015-05-281421876GLPG6-KUrl
2015-05-191421876GLPG6-KUrl

Galapagos NV
(NASDAQ:GLPG) 

GLPG stock logo

Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. Its clinical stage programs include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ul...

Founded: 1999
Full Time Employees: 1,407
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
The information provided in this report about GLPG stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.